NOA rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Disponible des:

Medis Pharma Pty Ltd

Designació comuna internacional (DCI):

rizatriptan benzoate

formulario farmacéutico:

Tablet, orally disintegrating

Composición:

Excipient Ingredients: crospovidone; calcium silicate; aspartame; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; mannitol; Flavour

Vía de administración:

Oral

Unidades en paquete:

3, 6, 2

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

NOA is indicated for the acute treatment of migraine attacks with or without aura.

Resumen del producto:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2015-02-19